Skip to main content
OpenTrials

Clinical trial condition

Sarcoma, Kaposi

Explore clinical trials studying Sarcoma, Kaposi. Study availability and eligibility vary by location and protocol.

129 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma, Kaposi trial results

Completed

A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

NCT00000763

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Bmc Actg Crs Boston, Massachusetts, United States
  • Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States
View Trial Details
Completed

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

NCT00000660

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • San Francisco Gen Hosp San Francisco, California, United States
  • Bellevue Hosp / New York Univ Med Ctr New York, United States
  • Mem Sloan - Kettering Cancer Ctr New York, United States
  • Saint Luke's - Roosevelt Hosp Ctr New York, United States
View Trial Details
Completed

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma

NCT00000695

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • USC School of Medicine / Norris Cancer Hosp Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
View Trial Details
Completed

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

NCT00001114

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • Stanford CRS Palo Alto, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

NCT00000954

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 14 locations
View Trial Details
Completed

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

NCT00000807

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • K Norris Cancer Hosp / Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • San Francisco Gen Hosp San Francisco, California, United States
View all 20 locations
View Trial Details

Related conditions